Raine Astin-Chamberlain

Sep 12, 2024 | emj.bmj.com | Jason Pott |Elaine Cole |Benjamin Bloom |Raine Astin-Chamberlain

AbstractBackground Female participants are underrepresented in randomised control trials conducted in urgent care settings. Although sex and gender are frequently reported within demographic data, it is less common for primary outcomes to be disaggregated by sex or gender.

Dec 31, 2023 | emj.bmj.com | Raine Astin-Chamberlain |Jason Pott |Elaine Cole |Benjamin Bloom

DiscussionThis review found that between 2010 and 2023, only 1 of 24 interventional trials (CRYOSTAT-2) disaggregated results by sex for the primary outcome.10 This trial was funded by the NIHR, which has not adopted the SAGER guidance and does not require reporting of sex-disaggregated treatment effects. The NIHR has published its own inclusivity statement, although that statement was published after CRYOSTAT-2 was awarded funding.